标题
Therapeutic Approaches in Lysosomal Storage Diseases
作者
关键词
-
出版物
Biomolecules
Volume 11, Issue 12, Pages 1775
出版商
MDPI AG
发表日期
2021-11-29
DOI
10.3390/biom11121775
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Lentivirus-mediated gene therapy for Fabry disease
- (2021) Aneal Khan et al. Nature Communications
- Impact of Long-Term Enzyme Replacement Therapy on Glucosylsphingosine (Lyso-Gb1) Values in Patients with Type 1 Gaucher Disease: Statistical Models for Comparing Three Enzymatic Formulations
- (2021) Tama Dinur et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Lentiviral hematopoietic stem and progenitor cell gene therapy (HSPC-GT) for metachromatic leukodystrophy (MLD): Clinical outcomes from 33 patients
- (2020) Francesca Fumagalli et al. MOLECULAR GENETICS AND METABOLISM
- First-in-human study of a liver-directed AAV gene therapy (FLT190) in Fabry disease
- (2020) Derralynn A. Hughes et al. MOLECULAR GENETICS AND METABOLISM
- Krabbe disease successfully treated via monotherapy of intrathecal gene therapy
- (2020) Allison M. Bradbury et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety of intrathecal delivery of recombinant human arylsulfatase A in children with metachromatic leukodystrophy: Results from a phase 1/2 clinical trial
- (2020) Christine í Dali et al. MOLECULAR GENETICS AND METABOLISM
- Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral Venglustat in Healthy Volunteers
- (2020) M. Judith Peterschmitt et al. Clinical Pharmacology in Drug Development
- Systemic treatment of Fabry disease using a novel AAV9 vector expressing α-Galactosidase A
- (2020) Maria Grazia Biferi et al. Molecular Therapy-Methods & Clinical Development
- AAV2/6 Gene Therapy in a Murine Model of Fabry Disease Results in Supraphysiological Enzyme Activity and Effective Substrate Reduction
- (2020) Makiko Yasuda et al. Molecular Therapy-Methods & Clinical Development
- Nanotechnology‐based approaches for treating lysosomal storage disorders, a focus on Fabry disease
- (2020) Ibane Abasolo et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- In Vitro and In Vivo Amenability to Migalastat in Fabry Disease
- (2020) Malte Lenders et al. Molecular Therapy-Methods & Clinical Development
- Long-term neurodevelopmental outcomes of hematopoietic stem cell transplantation for late-infantile Krabbe disease
- (2020) Isabel C. Yoon et al. BLOOD
- Adeno-associated virus vector as a platform for gene therapy delivery
- (2019) Dan Wang et al. NATURE REVIEWS DRUG DISCOVERY
- FACTs Fabry gene therapy clinical trial: Two-year data
- (2019) Jeffrey A. Medin et al. MOLECULAR GENETICS AND METABOLISM
- Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: a 1-year Phase 1/2 clinical trial
- (2019) Raphael Schiffmann et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study
- (2019) Dominique P. Germain et al. GENETICS IN MEDICINE
- Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT study
- (2019) Derralynn A. Hughes et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- The glycosylation design space for recombinant lysosomal replacement enzymes produced in CHO cells
- (2019) Weihua Tian et al. Nature Communications
- Intracerebroventricular enzyme replacement therapy with Beta-Galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice
- (2019) Joseph C Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- AAVrh10 Gene Therapy Ameliorates Central and Peripheral Nervous System Disease in Canine Globoid Cell Leukodystrophy (Krabbe Disease)
- (2018) Allison M. Bradbury et al. HUMAN GENE THERAPY
- Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort study
- (2018) Maarten Arends et al. JOURNAL OF MEDICAL GENETICS
- CRISPR-Cas guides the future of genetic engineering
- (2018) Gavin J. Knott et al. SCIENCE
- Iduronate-2-Sulfatase with Anti-human Transferrin Receptor Antibody for Neuropathic Mucopolysaccharidosis II: A Phase 1/2 Trial
- (2018) Torayuki Okuyama et al. MOLECULAR THERAPY
- Safety, tolerability, pharmacokinetics, pharmacodynamics, and exploratory efficacy of the novel enzyme replacement therapy avalglucosidase alfa (neoGAA) in treatment-naïve and alglucosidase alfa-treated patients with late-onset Pompe disease: a phase 1, open-label, multicenter, multinational, ascending dose study
- (2018) Loren D.M. Pena et al. NEUROMUSCULAR DISORDERS
- Lucerastat, an iminosugar with potential as substrate reduction therapy for glycolipid storage disorders: safety, tolerability, and pharmacokinetics in healthy subjects
- (2017) N. Guérard et al. Orphanet Journal of Rare Diseases
- Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid α-glucosidase
- (2017) Francesco Puzzo et al. Science Translational Medicine
- Development of idursulfase therapy for mucopolysaccharidosis type II (Hunter syndrome): the past, the present and the future
- (2017) David Whiteman et al. Drug Design Development and Therapy
- Gene editing for cell engineering: trends and applications
- (2016) Sanjeev K. Gupta et al. CRITICAL REVIEWS IN BIOTECHNOLOGY
- Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis
- (2016) Benedikt Schoser et al. JOURNAL OF NEUROLOGY
- Lysosomal Storage Diseases: From Pathophysiology to Therapy
- (2015) Giancarlo Parenti et al. Annual Review of Medicine
- In vivo genome editing of the albumin locus as a platform for protein replacement therapy
- (2015) R. Sharma et al. BLOOD
- Liver-targeted gene therapy: Approaches and challenges
- (2015) Rajagopal N. Aravalli et al. LIVER TRANSPLANTATION
- ENCORE, a randomized, controlled, open-label non-inferiority study comparing eliglustat to imiglucerase in Gaucher disease type 1 patients stabilized on enzyme replacement therapy: 24-month results
- (2015) Timothy M. Cox et al. MOLECULAR GENETICS AND METABOLISM
- Characterization of a chemically modified plant cell culture expressed human α-Galactosidase-A enzyme for treatment of Fabry disease
- (2015) Tali Kizhner et al. MOLECULAR GENETICS AND METABOLISM
- Pharmacological Chaperone Therapy: Preclinical Development, Clinical Translation, and Prospects for the Treatment of Lysosomal Storage Disorders
- (2015) Giancarlo Parenti et al. MOLECULAR THERAPY
- Oral Migalastat HCl Leads to Greater Systemic Exposure and Tissue Levels of Active α-Galactosidase A in Fabry Patients when Co-Administered with Infused Agalsidase
- (2015) David G. Warnock et al. PLoS One
- Eliglustat tartrate
- (2014) J.A. Shayman DRUGS OF THE FUTURE
- The Phytoestrogen Genistein Modulates Lysosomal Metabolism and Transcription Factor EB (TFEB) Activation
- (2014) Marta Moskot et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Pharmacological Chaperone AT2220 Increases the Specific Activity and Lysosomal Delivery of Mutant Acid Alpha-Glucosidase, and Promotes Glycogen Reduction in a Transgenic Mouse Model of Pompe Disease
- (2014) Richie Khanna et al. PLoS One
- Globotriaosylceramide Induces Endothelial Dysfunction in Fabry Disease
- (2013) Kimio Satoh ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- TFEB regulates lysosomal proteostasis
- (2013) Wensi Song et al. HUMAN MOLECULAR GENETICS
- Signals from the lysosome: a control centre for cellular clearance and energy metabolism
- (2013) Carmine Settembre et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Algorithm for the Early Diagnosis and Treatment of Patients with Cross Reactive Immunologic Material-Negative Classic Infantile Pompe Disease: A Step towards Improving the Efficacy of ERT
- (2013) Suhrad G. Banugaria et al. PLoS One
- Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy
- (2013) A. Biffi et al. SCIENCE
- Autophagy in lysosomal storage disorders
- (2012) Andrew P. Lieberman et al. Autophagy
- A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB
- (2012) Carmine Settembre et al. EMBO JOURNAL
- New strategies for the treatment of lysosomal storage diseases (Review)
- (2012) GIANCARLO PARENTI et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Miglustat-induced intestinal carbohydrate malabsorption is due to the inhibition of α-glucosidases, but not β-galactosidases
- (2012) Mahdi Amiri et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Long-Term Effect of Antibodies against Infused Alpha-Galactosidase A in Fabry Disease on Plasma and Urinary (lyso)Gb3 Reduction and Treatment Outcome
- (2012) Saskia M. Rombach et al. PLoS One
- Enzyme replacement therapy for lysosomal storage diseases
- (2011) Robin H. Lachmann CURRENT OPINION IN PEDIATRICS
- Transcriptional Activation of Lysosomal Exocytosis Promotes Cellular Clearance
- (2011) Diego L. Medina et al. DEVELOPMENTAL CELL
- The impact of antibodies on clinical outcomes in diseases treated with therapeutic protein: Lessons learned from infantile Pompe disease
- (2011) Suhrad G. Banugaria et al. GENETICS IN MEDICINE
- Production of active human glucocerebrosidase in seeds of Arabidopsis thaliana complex-glycan-deficient (cgl) plants
- (2011) Xu He et al. GLYCOBIOLOGY
- Intracerebroventricular enzyme infusion corrects central nervous system pathology and dysfunction in a mouse model of metachromatic leukodystrophy
- (2011) S. Stroobants et al. HUMAN MOLECULAR GENETICS
- Autophagy in skeletal muscle: implications for Pompe disease
- (2011) L. Shea et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Reversal of Lysosomal Storage in Brain of Adult MPS-I Mice with Intravenous Trojan Horse-Iduronidase Fusion Protein
- (2011) Ruben J. Boado et al. MOLECULAR PHARMACEUTICS
- Therapy for the mucopolysaccharidoses
- (2011) V. Valayannopoulos et al. RHEUMATOLOGY
- mTORC1 Senses Lysosomal Amino Acids Through an Inside-Out Mechanism That Requires the Vacuolar H+-ATPase
- (2011) R. Zoncu et al. SCIENCE
- HSP70 and lysosomal storage disorders: novel therapeutic opportunities
- (2010) Nikolaj H.T. Petersen et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids
- (2010) Yasemin Sancak et al. CELL
- Lysosomal Storage Disease: Revealing Lysosomal Function and Physiology
- (2010) Emma J. Parkinson-Lawrence et al. PHYSIOLOGY
- Glycan Engineering and Production of ‘Humanized’ Glycoprotein in Yeast Cells
- (2009) Yasunori Chiba et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- The pharmacological chaperone 1-deoxynojirimycin increases the activity and lysosomal trafficking of multiple mutant forms of acid alpha-glucosidase
- (2009) John J. Flanagan et al. HUMAN MUTATION
- Catalytic Mechanism of Human α-Galactosidase
- (2009) Abigail I. Guce et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Long-Term Miglustat Therapy in Children With Niemann-Pick Disease Type C
- (2009) Marc C. Patterson et al. JOURNAL OF CHILD NEUROLOGY
- AAV9: a potential blood-brain barrier buster
- (2009) Fredric P Manfredsson et al. MOLECULAR THERAPY
- A Gene Network Regulating Lysosomal Biogenesis and Function
- (2009) Marco Sardiello et al. SCIENCE
- Transplant Outcomes in Leukodystrophies
- (2009) Paul J. Orchard et al. SEMINARS IN HEMATOLOGY
- Isofagomine increases lysosomal delivery of exogenous glucocerebrosidase
- (2008) Jin-Song Shen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Sorting of lysosomal proteins
- (2008) Thomas Braulke et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Chemical and Biological Approaches Synergize to Ameliorate Protein-Folding Diseases
- (2008) Ting-Wei Mu et al. CELL
- Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium
- (2008) Emyr Lloyd-Evans et al. NATURE MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now